Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-135603
Filing Date
2021-04-28
Accepted
2021-04-28 08:45:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d132478ddefa14a.htm DEFA14A 85462
2 GRAPHIC g132478g01h67.jpg GRAPHIC 37900
3 GRAPHIC g132478g02j68.jpg GRAPHIC 156357
4 GRAPHIC g132478g03l62.jpg GRAPHIC 1776
5 GRAPHIC g132478g0423135242265.jpg GRAPHIC 2730
6 GRAPHIC g132478g30j82.jpg GRAPHIC 97219
  Complete submission text file 0001193125-21-135603.txt   494905
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 21861549
SIC: 2836 Biological Products, (No Diagnostic Substances)